Report Detail
Global Pediatric Drug Development Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4720914 |
- 29 June, 2026 |
- Global |
- 104 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global Pediatric Drug Development Services market size was valued at US$ 1367 million in 2025 and is forecast to a readjusted size of US$ 1977 million by 2032 with a CAGR of 5.5% during review period.
Pediatric drug development services refer to professional services for drug research and development tailored to the needs of pediatric patients. These services include drug safety assessment, pharmacodynamics studies, clinical trial design, and other aspects. Pediatric Drug Development Services aim to ensure the safety and efficacy of drugs in pediatric patients, providing more appropriate treatment options for children. This service is of great significance in the field of pediatrics, contributing to improved child health and quality of life.
This report is a detailed and comprehensive analysis for global Pediatric Drug Development Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pediatric Drug Development Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Pediatric Drug Development Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Pediatric Drug Development Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Pediatric Drug Development Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pediatric Drug Development Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pediatric Drug Development Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IQVIA, Lonza, Fortrea, Certara, NGT BioPharma, PCI, Allucent, CTI, Sun-Novo, ICON, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Pediatric Drug Development Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Preclinical Services
Clinical Services
Market segment by Application
Pharmaceutical Companies
Medical Device Companies
Others
Market segment by players, this report covers
IQVIA
Lonza
Fortrea
Certara
NGT BioPharma
PCI
Allucent
CTI
Sun-Novo
ICON
Lewwin Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pediatric Drug Development Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pediatric Drug Development Services, with revenue, gross margin, and global market share of Pediatric Drug Development Services from 2021 to 2026.
Chapter 3, the Pediatric Drug Development Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Pediatric Drug Development Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pediatric Drug Development Services.
Chapter 13, to describe Pediatric Drug Development Services research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Pediatric Drug Development Services by Type
- 1.3.1 Overview: Global Pediatric Drug Development Services Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Pediatric Drug Development Services Consumption Value Market Share by Type in 2025
- 1.3.3 Preclinical Services
- 1.3.4 Clinical Services
- 1.4 Global Pediatric Drug Development Services Market by Application
- 1.4.1 Overview: Global Pediatric Drug Development Services Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Pharmaceutical Companies
- 1.4.3 Medical Device Companies
- 1.4.4 Others
- 1.5 Global Pediatric Drug Development Services Market Size & Forecast
- 1.6 Global Pediatric Drug Development Services Market Size and Forecast by Region
- 1.6.1 Global Pediatric Drug Development Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Pediatric Drug Development Services Market Size by Region, (2021-2032)
- 1.6.3 North America Pediatric Drug Development Services Market Size and Prospect (2021-2032)
- 1.6.4 Europe Pediatric Drug Development Services Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Pediatric Drug Development Services Market Size and Prospect (2021-2032)
- 1.6.6 South America Pediatric Drug Development Services Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Pediatric Drug Development Services Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 IQVIA
- 2.1.1 IQVIA Details
- 2.1.2 IQVIA Major Business
- 2.1.3 IQVIA Pediatric Drug Development Services Product and Solutions
- 2.1.4 IQVIA Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 IQVIA Recent Developments and Future Plans
- 2.2 Lonza
- 2.2.1 Lonza Details
- 2.2.2 Lonza Major Business
- 2.2.3 Lonza Pediatric Drug Development Services Product and Solutions
- 2.2.4 Lonza Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Lonza Recent Developments and Future Plans
- 2.3 Fortrea
- 2.3.1 Fortrea Details
- 2.3.2 Fortrea Major Business
- 2.3.3 Fortrea Pediatric Drug Development Services Product and Solutions
- 2.3.4 Fortrea Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Fortrea Recent Developments and Future Plans
- 2.4 Certara
- 2.4.1 Certara Details
- 2.4.2 Certara Major Business
- 2.4.3 Certara Pediatric Drug Development Services Product and Solutions
- 2.4.4 Certara Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Certara Recent Developments and Future Plans
- 2.5 NGT BioPharma
- 2.5.1 NGT BioPharma Details
- 2.5.2 NGT BioPharma Major Business
- 2.5.3 NGT BioPharma Pediatric Drug Development Services Product and Solutions
- 2.5.4 NGT BioPharma Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 NGT BioPharma Recent Developments and Future Plans
- 2.6 PCI
- 2.6.1 PCI Details
- 2.6.2 PCI Major Business
- 2.6.3 PCI Pediatric Drug Development Services Product and Solutions
- 2.6.4 PCI Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 PCI Recent Developments and Future Plans
- 2.7 Allucent
- 2.7.1 Allucent Details
- 2.7.2 Allucent Major Business
- 2.7.3 Allucent Pediatric Drug Development Services Product and Solutions
- 2.7.4 Allucent Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Allucent Recent Developments and Future Plans
- 2.8 CTI
- 2.8.1 CTI Details
- 2.8.2 CTI Major Business
- 2.8.3 CTI Pediatric Drug Development Services Product and Solutions
- 2.8.4 CTI Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 CTI Recent Developments and Future Plans
- 2.9 Sun-Novo
- 2.9.1 Sun-Novo Details
- 2.9.2 Sun-Novo Major Business
- 2.9.3 Sun-Novo Pediatric Drug Development Services Product and Solutions
- 2.9.4 Sun-Novo Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Sun-Novo Recent Developments and Future Plans
- 2.10 ICON
- 2.10.1 ICON Details
- 2.10.2 ICON Major Business
- 2.10.3 ICON Pediatric Drug Development Services Product and Solutions
- 2.10.4 ICON Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 ICON Recent Developments and Future Plans
- 2.11 Lewwin Pharma
- 2.11.1 Lewwin Pharma Details
- 2.11.2 Lewwin Pharma Major Business
- 2.11.3 Lewwin Pharma Pediatric Drug Development Services Product and Solutions
- 2.11.4 Lewwin Pharma Pediatric Drug Development Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Lewwin Pharma Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Pediatric Drug Development Services Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Pediatric Drug Development Services by Company Revenue
- 3.2.2 Top 3 Pediatric Drug Development Services Players Market Share in 2025
- 3.2.3 Top 6 Pediatric Drug Development Services Players Market Share in 2025
- 3.3 Pediatric Drug Development Services Market: Overall Company Footprint Analysis
- 3.3.1 Pediatric Drug Development Services Market: Region Footprint
- 3.3.2 Pediatric Drug Development Services Market: Company Product Type Footprint
- 3.3.3 Pediatric Drug Development Services Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Pediatric Drug Development Services Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Pediatric Drug Development Services Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Pediatric Drug Development Services Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Pediatric Drug Development Services Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Pediatric Drug Development Services Consumption Value by Type (2021-2032)
- 6.2 North America Pediatric Drug Development Services Market Size by Application (2021-2032)
- 6.3 North America Pediatric Drug Development Services Market Size by Country
- 6.3.1 North America Pediatric Drug Development Services Consumption Value by Country (2021-2032)
- 6.3.2 United States Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 6.3.3 Canada Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Pediatric Drug Development Services Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Pediatric Drug Development Services Consumption Value by Type (2021-2032)
- 7.2 Europe Pediatric Drug Development Services Consumption Value by Application (2021-2032)
- 7.3 Europe Pediatric Drug Development Services Market Size by Country
- 7.3.1 Europe Pediatric Drug Development Services Consumption Value by Country (2021-2032)
- 7.3.2 Germany Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 7.3.3 France Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 7.3.5 Russia Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 7.3.6 Italy Pediatric Drug Development Services Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Pediatric Drug Development Services Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Pediatric Drug Development Services Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Pediatric Drug Development Services Market Size by Region
- 8.3.1 Asia-Pacific Pediatric Drug Development Services Consumption Value by Region (2021-2032)
- 8.3.2 China Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 8.3.3 Japan Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 8.3.5 India Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 8.3.7 Australia Pediatric Drug Development Services Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Pediatric Drug Development Services Consumption Value by Type (2021-2032)
- 9.2 South America Pediatric Drug Development Services Consumption Value by Application (2021-2032)
- 9.3 South America Pediatric Drug Development Services Market Size by Country
- 9.3.1 South America Pediatric Drug Development Services Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Pediatric Drug Development Services Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Pediatric Drug Development Services Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Pediatric Drug Development Services Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Pediatric Drug Development Services Market Size by Country
- 10.3.1 Middle East & Africa Pediatric Drug Development Services Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Pediatric Drug Development Services Market Size and Forecast (2021-2032)
- 10.3.4 UAE Pediatric Drug Development Services Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Pediatric Drug Development Services Market Drivers
- 11.2 Pediatric Drug Development Services Market Restraints
- 11.3 Pediatric Drug Development Services Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Pediatric Drug Development Services Industry Chain
- 12.2 Pediatric Drug Development Services Upstream Analysis
- 12.3 Pediatric Drug Development Services Midstream Analysis
- 12.4 Pediatric Drug Development Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Pediatric Drug Development Services. Industry analysis & Market Report on Pediatric Drug Development Services is a syndicated market report, published as Global Pediatric Drug Development Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pediatric Drug Development Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
